shackel
success
treatment
rabi
viru
repres
first
publish
account
preserv
anim
viru
use
process
earli
version
freezedri
shackel
prior
virus
maintain
passag
anim
howev
freezedri
provid
way
maintain
viral
infect
materi
long
period
time
rel
eas
compar
serial
passag
suscept
anim
host
first
experi
demonstr
method
could
provid
longterm
stabil
report
bovin
viru
freezedri
shown
viabl
maintain
room
temperatur
year
fasquel
barbier
later
mechan
freezer
becam
avail
freez
virus
less
adopt
practic
reliabl
method
viru
preserv
influenza
virusinfect
mous
lung
tissu
yellow
fever
viru
success
frozen
turner
horsfal
use
turner
method
demonstr
success
storag
influenza
mous
pneumon
canin
distemp
virus
follow
earli
success
viral
repositori
diagnost
research
laboratori
vaccin
manufactur
facil
reli
freez
freezedri
preserv
virus
viral
vaccin
reason
preserv
virus
similar
preserv
microorgan
cell
success
preserv
allow
longterm
mainten
consist
stock
reproduc
test
viral
sampl
manufactur
vaccin
exampl
field
clinic
isol
need
preserv
transport
test
laboratori
harvest
viru
anim
cell
cultur
may
process
immedi
requir
preserv
use
virus
held
low
number
passag
anim
cell
cultur
repres
viral
popul
similar
found
natur
freez
pool
guard
genet
mutat
may
occur
subsequ
passag
aliquot
viral
stock
frozen
design
passag
level
use
multipl
repeat
experi
viral
popul
furthermor
extrem
import
consist
maintain
product
viral
vaccin
new
lot
final
product
prepar
frozen
viral
seed
stock
consist
reproduc
desir
immunogen
attenu
characterist
exampl
world
health
organ
maintain
aliquot
origin
attenu
polioviru
strain
develop
dr
albert
sabin
aliquot
frozen
amplifi
properli
kept
prescrib
low
passag
level
produc
vaccin
today
properti
character
origin
sabin
vaccin
similarli
virus
current
develop
use
vector
gene
therapi
must
highli
character
homogen
safe
effect
use
need
maintain
frozen
stock
order
better
appreci
requir
freez
freezedri
human
anim
virus
consider
must
first
given
understand
structur
function
organ
divers
group
microorgan
classif
virus
base
morpholog
physiochem
properti
thu
virus
divid
dna
rna
genom
subdivid
famili
base
size
structur
properti
famili
dna
virus
famili
rna
virus
see
tabl
genom
virus
within
given
famili
similar
term
polar
genom
organ
method
replic
morpholog
featur
common
includ
size
shape
nucleocapsid
symmetri
presenc
absenc
envelop
characterist
help
classifi
virus
includ
sensit
low
ph
heat
lipid
solvent
sensit
ph
determin
subject
viru
ph
loss
titer
greater
one
indic
viru
ph
sensit
acid
labil
heat
treatment
viru
min
test
thermal
stabil
viru
surviv
treatment
one
loss
infect
consid
thermost
treatment
lipid
solvent
commonli
ether
despit
similar
among
physic
properti
famili
virus
rel
gener
rule
freez
freezedri
virus
made
exampl
common
use
membranestabil
agent
preserv
virus
lipid
envelop
picornavirus
lack
lipid
membran
maintain
infect
presenc
howev
optim
condit
freez
specif
virus
need
determin
empir
signific
reduct
morbid
mortal
mani
viral
infect
accomplish
success
applic
viral
vaccin
case
smallpox
erad
import
human
pathogen
realiz
polio
target
next
viral
diseas
erad
immun
vaccin
product
requir
use
seed
lot
system
consist
reproduct
qualiti
control
vaccin
lot
vaccin
viru
seed
usual
frozen
two
passag
level
prior
vaccin
lot
product
stock
viru
design
master
seed
product
work
seed
respect
multipl
aliquot
seed
prepar
refer
well
character
standard
test
possibl
contamin
final
also
import
distribut
storag
master
viru
seed
work
seed
among
multipl
freezer
order
assur
preserv
part
stock
event
mechan
failur
seed
lot
system
establish
viral
stock
standard
provid
sourc
virus
vaccin
lot
manufactur
decad
close
relat
origin
seed
lot
especi
import
liveattenu
vaccin
case
deriv
multipl
serial
passag
clinic
isol
viru
deviat
attenu
passag
number
may
result
undesir
phenotyp
chang
attenu
vaccin
viru
case
yellow
fever
vaccin
uncontrol
passag
viru
result
vaccin
higher
normal
incid
side
reaction
fox
et
al
present
research
use
tool
molecular
biolog
produc
new
class
recombin
viral
agent
use
immun
genet
therapi
exampl
mammalian
retrovirus
integr
host
cell
genom
develop
vector
deliveri
human
dna
sequenc
newli
acquir
dna
express
form
protein
may
defici
host
cell
may
requir
de
novo
synthesi
form
genet
therapi
demonstr
routin
vitro
vivo
anim
experi
propos
therapi
human
genet
diseas
review
see
roemer
friedmann
addit
recombin
viral
vector
also
pave
way
novel
type
therapi
cancer
cell
specif
target
infect
recombin
viru
follow
infect
insert
gene
express
gene
product
select
make
infect
cancer
cell
suscept
subsequ
chemotherapi
natur
immun
surveil
host
collin
et
al
culver
et
al
altern
recombin
vector
may
express
antisens
rna
bind
block
activ
host
gene
sequenc
success
experi
kind
requir
viral
vector
thoroughli
character
safe
seed
stock
recombin
viral
vector
construct
express
desir
nonvir
gene
sequenc
must
frozen
freezedri
order
preserv
futur
experi
clinic
trial
somewhat
similar
approach
develop
vaccin
use
viral
vector
deliveri
vehicl
gene
import
immun
exampl
one
approach
use
highli
attenu
vaccinia
viru
carri
part
genom
variou
immunogen
protein
would
evok
protect
infect
moss
flexner
viral
vector
use
similarli
includ
adenoviru
canarypox
antigen
use
viral
diagnost
purpos
must
also
qualiti
control
gener
would
also
produc
viru
seed
lot
system
variat
qualiti
quantiti
viral
antigen
diagnost
kit
reagent
may
directli
influenc
result
diagnost
laboratori
regul
manufactur
diagnost
similar
vaccin
manufactur
regul
concern
manufactur
biolog
product
publish
unit
state
public
health
servic
cfr
outlin
requir
control
reagent
raw
materi
manufactur
diagnost
screen
blood
blood
product
purpos
essenti
use
viral
seed
stock
appropri
character
preserv
freez
viabil
virus
usual
determin
use
infect
assay
includ
assay
wherebi
viral
cytopatholog
measur
cell
cultur
possibl
potenc
may
determin
inocul
anim
egg
far
accept
accur
quantit
measur
viral
infect
plaqu
assay
virus
form
plaqu
suscept
host
cell
gener
viru
inocul
suitabl
sensit
cell
monolay
agar
overlay
appli
viral
cytopatholog
local
incub
period
viabl
cell
stain
vital
dye
reveal
area
cell
death
plaqueform
unit
viral
freez
recoveri
experi
use
plaqu
assay
titer
viru
treatment
measur
viral
activ
way
one
determin
effici
freez
freezedri
process
electron
microscopi
em
also
use
occas
visual
effect
freez
freezedri
em
experi
limit
puriti
titer
viral
prepar
well
subject
interpret
observ
success
freez
freezedri
virus
depend
proper
prepar
harvest
viru
sourc
viru
may
anim
tissu
organ
anim
sera
virusinfect
cell
cultur
occas
egg
allanto
amniot
fluid
harvest
tissu
depend
particular
hostrang
viru
grown
harvest
method
also
depend
properti
viral
replic
virus
eg
herp
virus
stay
cell
associ
wherea
readili
releas
cell
cultur
fluid
gener
virus
grown
passag
vivo
requir
disrupt
infect
anim
tissu
organ
homogen
aerosolcontrol
blender
diluent
consist
buffer
cell
cultur
media
ad
releas
viru
aqueou
phase
cell
disrupt
depend
viru
serum
may
requir
addit
diluent
optim
freez
tabl
virus
found
blood
may
harvest
frozen
directli
serum
separ
blood
cell
cocultiv
infect
peripher
blood
lymphocyt
pbl
suscept
cell
line
prepar
may
frozen
without
treatment
although
gener
recommend
serum
pbl
frozen
thaw
achiev
optim
viru
recoveri
similarli
cell
cultur
harvest
may
requir
disrupt
cell
monolay
first
step
cell
may
scrape
cultur
vessel
surfac
cultur
fluid
fluid
may
remov
cell
treat
separ
either
case
cell
disrupt
viru
releas
certain
case
virusinfect
cell
harvest
seed
prepar
gentl
scrape
harvest
cell
cultur
fluid
flesh
buffer
cell
cultur
medium
requir
specif
detail
optim
harvest
procedur
individu
virus
may
found
literatur
usual
anim
serum
use
compon
cell
cultur
medium
fetal
bovin
serum
fb
frequent
use
addit
cell
culturist
virologist
nontox
cell
protect
effect
freez
consist
therefor
fb
doubl
cell
nutrit
well
cryoprotect
freez
freezedri
concentr
use
cell
cultur
grow
virus
rang
cell
cultur
medium
mani
case
cell
cultur
medium
contain
serum
constitut
cyroprotect
diluent
use
freez
howev
addit
serum
requir
mani
virus
see
tabl
infecti
materi
handl
accord
biosafeti
guidelin
appli
viru
rate
freez
final
temperatur
must
consid
viru
prepar
frozen
longterm
storag
maintain
viral
infect
throughout
process
integr
viral
capsid
viral
envelop
one
viral
nucleic
acid
must
preserv
dimmock
demonstr
viral
infect
may
reduc
heat
damag
viral
protein
nucleic
acid
show
stabil
compon
vari
elev
temperatur
inactiv
particular
temperatur
take
place
whichev
compon
least
stabl
temperatur
gener
virus
may
snap
frozen
dri
iceethanol
bath
prior
storag
temperatur
may
prefer
freez
virus
cytomegaloviru
varicellazost
viru
viabl
infect
cell
case
slow
control
rate
freez
recommend
cool
done
l
simion
brown
also
report
influenza
measl
viru
may
benefit
twostep
freez
process
row
snowman
storag
temperatur
also
critic
virus
envelop
influenza
viru
respiratori
syncyti
viru
measl
viru
requir
storag
lower
optim
recoveri
longterm
storag
rightsel
greiff
greiff
et
al
law
hull
common
practic
today
virologist
store
frozen
virus
ultralowtemperatur
freezer
temperatur
freez
liquid
nitrogen
vapor
phase
common
practic
preserv
mammalian
cell
necessari
virus
liquid
nitrogen
storag
may
use
backup
system
viral
seed
repositori
known
convent
viru
requir
liquid
vapor
nitrogen
shortor
longterm
storag
cryoprotect
one
first
comprehens
studi
freez
freezedri
repres
member
rna
dna
viru
famili
rightsel
greiff
demonstr
import
suspend
medium
use
freez
freezedri
medium
contain
skim
milk
calcium
lactobion
normal
serum
albumin
dimethyl
sulfoxid
dmso
glycerol
magnesium
chlorid
promot
better
freez
freezedri
recoveri
rang
virus
especi
envelop
rna
virus
walli
melnick
demonstr
dmso
serum
act
cryoprotect
four
differ
envelop
virus
herp
viru
measl
viru
sindbi
viru
vesicular
stomat
viru
condit
describ
dmso
perform
somewhat
better
serum
cryoprotect
nonenvelop
virus
vaccinia
adenoviru
polioviru
requir
dmso
serum
retent
viabil
freez
author
conclud
envelop
virus
similar
mammalian
cell
dmso
stabil
viral
envelop
much
stabil
mammalian
plasma
membran
howev
anoth
member
herp
viru
famili
varicellazost
vz
especi
sensit
freez
freezedri
grose
et
al
use
sucros
potassium
phosphat
sodium
glutam
albumin
cryoprotect
cocktail
vz
viru
cellassoci
cellfre
viru
cocktail
fulli
protect
recoveri
infect
freez
freezedri
addit
author
found
glutam
albumin
could
remov
cocktail
without
loss
protect
contrast
scott
woodsid
show
sodium
glutam
essenti
stabil
freezedri
herp
viru
certain
virus
stabil
addit
dival
cation
exampl
respiratori
syncyti
viru
found
stabl
month
follow
addit
magnesium
sulfat
titer
viru
maintain
sever
cycl
freez
thaw
ad
ferni
gerin
likewis
polioviru
stabil
presenc
melnick
et
al
altern
mm
sodium
phosphat
ph
stabil
polioviru
month
mauler
gruschkau
cryoprotect
rate
freez
minim
format
ice
crystal
damag
virus
similarli
common
practic
rapidli
thaw
frozen
viral
stock
previous
determin
optim
temperatur
minim
ice
crystal
format
freezedri
lyophil
method
preserv
virus
biolog
materi
remov
water
frozen
sampl
via
sublim
result
dri
prepar
usual
stabl
wetfrozen
prepar
variou
temperatur
longer
period
process
usual
divid
three
stage
prefreez
sublim
dri
vacuum
primari
dri
desorpt
secondari
dri
prefreez
accomplish
special
freezer
freezedry
freezedry
vaccuum
pump
remov
air
chamber
hold
vial
materi
freezedri
water
vapor
gener
process
condens
refriger
trap
allow
enter
vacuum
pump
rate
sublim
control
regul
heat
transfer
frozen
materi
final
dri
inert
ga
use
fill
vial
protect
freezedri
materi
deleteri
effect
oxygen
freezedri
cycl
requir
optim
viru
typic
cycl
use
success
dengu
liveattenu
viru
vaccin
four
serotyp
consist
freez
hour
allow
condens
reach
temperatur
k
eckel
unpublish
data
vacuum
drawn
hg
time
heat
appli
control
rate
overnight
approxim
hour
final
dri
occur
hour
follow
backfil
vial
dri
steril
nitrogen
cap
vaccin
vial
final
store
anoth
cycl
preserv
viral
infect
use
dengu
candid
vaccin
consist
freez
overnight
follow
rais
temperatur
final
period
vaccuum
appli
k
eckel
unpublish
data
case
care
taken
avoid
subject
thermolabil
viru
prolong
period
high
temperatur
could
result
inactiv
viral
infect
greiff
rightsel
success
freezedri
influenza
measl
viru
cycl
extend
period
shelf
product
temperatur
exceed
greiff
outlin
approach
develop
success
freezedri
cycl
similarli
vari
dri
time
shelf
temperatur
vacuum
pressur
optim
lyophil
cycl
varicellazost
vaccin
determin
bennett
et
al
freezedri
method
cycl
use
american
type
cultur
collect
atcc
viru
stock
found
simion
brown
stabil
ad
viral
suspens
medium
freezedri
mani
use
freez
addit
promot
preserv
viral
infect
act
antioxid
provid
bulk
viru
prepar
allow
easier
reconstitut
also
nonhygroscop
avoid
moistur
contamin
freezedri
materi
vaccin
stabil
must
also
nonimmunogen
nonreact
vaccin
recipi
one
first
stabil
use
viral
freezedri
gum
acacia
preserv
infect
vaccinia
viru
river
ward
pepton
normal
hors
serum
also
success
use
freezedri
vaccinia
viru
collier
spark
fenj
calcium
lactobion
human
serum
albumin
cryoprotect
measl
viru
freezedri
greiff
rightsel
wherea
cell
cultur
medium
alon
less
protect
combin
sucros
phosphat
sodium
glutam
albumin
use
freezedri
pseudorabi
herp
virus
scott
woodsid
calnek
et
al
varicellazost
viru
also
freezedri
success
combin
stabil
grose
found
could
elimin
glutam
albumin
mixtur
still
retain
recoveri
labil
viru
dmso
use
stabil
freezedri
prepar
becom
concentr
toxic
level
greiff
rightsel
group
virus
requir
special
attent
stabil
media
enterovirus
exampl
polioviru
hepat
viru
earli
work
polioviru
demonstr
high
degre
labil
freezedri
even
stabil
labil
due
presenc
inorgan
salt
may
present
cultur
medium
remov
dialysi
prior
freezedri
loss
occur
berg
et
al
atcc
use
ultrafiltr
rapid
type
dialysi
remov
salt
prior
freezedri
enterovirus
simion
brown
vaccin
requir
freezedri
special
stabil
requir
allow
use
safe
human
anim
serum
use
stabil
must
complet
remov
vaccin
prior
bottl
protein
substitut
requir
human
serum
albumin
use
success
mani
vaccin
recent
hydrolyz
gelatin
use
replac
albumin
tabl
stabil
accept
human
vaccin
usual
stimul
deleteri
immun
respons
vaccine
sugar
sucros
lactos
sorbitol
also
use
either
alon
combin
protein
stabil
cell
cultur
medium
often
use
buffer
mani
live
vaccin
harvest
cultur
medium
without
process
optim
moistur
content
freezedri
product
need
empir
determin
viral
prepar
good
freezedri
cycl
attain
moistur
content
less
final
product
howev
depend
viru
higher
moistur
content
may
desir
varicella
viru
vaccin
moistur
follow
freezedri
found
stabl
vaccin
contain
less
moistur
bennett
et
al
variou
virus
freezedri
approxim
moistur
shown
stabl
period
time
better
longterm
stabil
achiev
storag
stabil
assay
retain
infect
follow
freezedri
done
rehydr
vial
freezedri
viru
volum
steril
distil
water
use
reconstitut
vial
titrat
viru
done
immedi
appropri
plaqu
infect
assay
best
control
baselin
infect
would
viru
harvest
assay
prior
freezedri
often
frozen
thaw
specimen
use
baselin
titer
freezedri
virus
normal
store
acceler
stabil
studi
done
test
thermost
shorter
period
elev
temperatur
often
ambient
temperatur
temperatur
use
acceler
studi
temperatur
chosen
studi
thermost
virus
mainli
vaccin
may
continu
refriger
avail
time
use
problem
mani
live
viral
vaccin
use
develop
countri
widdu
et
al
largest
applic
freezedri
virus
occur
liveattenu
viral
vaccin
thermolabil
first
viral
vaccin
freezedri
yellow
fever
vaccin
penna
recent
advanc
result
stabl
freezedri
yellow
fever
vaccin
robin
et
al
burfoot
et
al
standard
stabil
vaccin
one
loss
potenc
held
week
recent
collabor
studi
yellow
fever
vaccin
manufactur
demonstr
vaccin
met
requir
similar
stabil
standard
place
live
freezedri
measl
vaccin
method
freezedri
stabil
trival
live
attenu
oral
polio
vaccin
sought
vaccin
deliv
use
develop
countri
without
signific
loss
potenc
propos
thermoresist
mutant
poliovirus
might
serv
prototyp
develop
heatstabl
vaccin
strain
kew
altern
organ
compound
win
r
bind
poliviru
found
increas
halflif
polioviru
antigen
temperatur
rombaut
et
al
drug
stabil
conform
viral
capsid
exhibit
potent
antivir
effect
would
make
suitabl
stabil
live
viru
vaccin
futur
similar
compound
could
design
stabil
inhibit
replic
live
polioviru
strain
licens
freezedri
livevir
vaccin
mump
rubella
wherea
vaccin
varicella
chicken
pox
cytomegalovirus
develop
requir
stabil
freezedri
tabl
list
licens
vaccin
well
still
test
avail
publish
data
freezedri
vaccin
american
type
cultur
collect
parklawn
drive
rockvil
maryland
telephon
unit
state
canada
fax
request
intern
refer
materi
made
statement
intent
investig
